KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Accumulated Depreciation & Amortization (2016 - 2025)

Quest Diagnostics' Accumulated Depreciation & Amortization history spans 17 years, with the latest figure at $570.0 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 15.62% year-over-year to $570.0 million; the TTM value through Dec 2025 reached $570.0 million, up 15.62%, while the annual FY2025 figure was $570.0 million, 15.62% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $570.0 million at Quest Diagnostics, up from $493.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $570.0 million in Q4 2025 and bottomed at $408.0 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $439.0 million (2023), against an average of $469.4 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization rose 0.46% in 2023 before it grew 15.62% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $408.0 million in 2021, then rose by 7.11% to $437.0 million in 2022, then increased by 0.46% to $439.0 million in 2023, then rose by 12.3% to $493.0 million in 2024, then increased by 15.62% to $570.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Accumulated Depreciation & Amortization are $570.0 million (Q4 2025), $493.0 million (Q4 2024), and $439.0 million (Q4 2023).